Q4 2022
Released Mar 28, 2023, before the open
10-K filed Mar 29, 2023, 88 days after period end · 0000868278-23-000004
Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$21.82M$21.82M derived−51.7% vs Q4 2021−9.8% vs Q3 2022
Net Income-$2.45M-$2.45M derivedN/M vs Q4 2021N/M vs Q3 2022
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$11,284,000−54.2%
Operating Incomederived-$5,091,000N/M
Operating Cash Flowderived$811,000N/M
Free Cash Flowderived-$785,000N/M
Margins · derived
Gross margin51.7%−2.8 pt vs Q4 2021
Operating margin-23.3%−53.6 pt vs Q4 2021
Net margin-11.2%−34.7 pt vs Q4 2021
What the release said
The release
Same quarter
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $21.82M | $45.16M | $5.16M | $3.14M |
| Net Income | -$2.45M | $10.59M | -$978.00K | -$467.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR